UK small-cap RNS · 15 Jan 2026
Every announcement of UK small & mid caps under £2bn. The ones that started or moved a situation are marked – a click opens it.
Sort: Newest · Largest companies
-
15:02
Replacement - Trading Update Trading updateFY2025 revenue rose 33% in KZT on 21% higher volumes and 10% higher prices, with the plant at maximum capacity, so growth is now limited by capacity. USD price was slightly lower.Moved: Clinker line 6 capacity expansion: Decided; debt financing and EPC contractors pending → Decided; costed at USD 35m; financing and contractors pending
-
10:45
Trading Update, Board Changes and Investment Plan Trading updateChair Xavier Blutel steps down and CEO Javier del Ser moves up to Executive Chairman. This is an internal reshuffle that combines the chair and executive roles, and the board stays small.Moved: new: Clinker line 6 capacity expansion – Decided; debt financing and EPC contractors pending
-
07:00
Alumasc Group ALU £83mDirectorate Change Board changePamela Bingham, an experienced international manufacturing CEO, succeeds Paul Hooper. Planned succession with no trading news, so little near-term effect, though it brings a new strategy and execution risk.New CEO / reset +0.0% on the dayMoved: new: CEO succession – Successor named; Hooper retires 31 March
-
07:00
Full Year Trading Update Trading update("DF Capital" or the "Company" together with its subsidiaries the "Group")
-
07:00
Diaceutics DXRX £166mFull Year 2025 Trading Update Trading updateThis is a full-year trading update, not a guidance raise. Adjusted EBITDA is above consensus, constant-currency revenue is in line, and FY 2026 growth of 25% is guided for the first time. Reported revenue is below the £39.5m consensus.Moved: new: FY 2026 revenue growth guidance – 25% FY 2026 revenue growth guided
-
07:00
Robert Walters RWA £87mQ4 2025 Trading Update Trading updateQ4 NFI fell 14% with 2025 down 14%, and 2026 NFI is planned slightly below 2025. UK, Spain and ANZ are recovering, but northern Europe is weak. Costs and net cash are steady.Moved: new: Cost savings and portfolio management – Run rate below £24m; £10m target by 2027 · new: Market recovery and 2026 NFI – 2026 NFI planned slightly below 2025
-
07:00
Trufin TRU £54mTrading Update Trading updatePBT guidance lifted again from above £7.0m (11 Dec) to above £7.4m, with EBITDA above £11.8m and revenue about £63.0m, all above the December floors, driven by Playstack.Turnaround plan with targets £8.0m · 15% of mcapahead of expectationsoutlook positive, raised +1.7% on the dayMoved: Record first annual Profit Before Tax in 2025.: on_track → delivered – FY25 PBT expected above £7.4m, up more than 720% from £0.9m, a record profit year. · Group to grow all profitability lines in 2025 and beyond.: on_track → delivered – Revenue, adjusted EBITDA and PBT all expected to rise in FY25 versus FY24. · Buy back up to £4m of shares by 31 December 2025.: pending → delivered – Two buybacks totalling £8.0m were completed in 2025, double the £4m target.
-
07:00
Second Quarter FUMA UpdateQ2 FUMA update shows FUMA up 3% to £20.1bn and a return to net inflows, supporting the 'Reignite Growth' strategy after prior net outflows.Moved: new: Reignite Growth strategy – First net inflow quarter since FY 2023
-
07:00
Newmark Security PLC NWT £9.1mHalf-year Results ResultsH1 revenue up 13% to £11.6m with EBITDA of £0.9m and the loss after tax cut to £0.1m, as the chairman's October 'strong results' pre-signal said. Both divisions improved and H2 is guided stronger.Sale process / strategic review ahead of expectationsoutlook positivefirst in 11 months +2.2% on the dayMoved: Obtain Workday certification by mid-FY26 and build pipeline: pending → on_track – Workday integration is stated to be in place, but certification is not mentioned, so it is not confirmed. · Complete development of next-generation access control product in the next finan: pending → delayed – The Janus C4 Ultra access control product is held back by software partner delays; investment was refocused on HCM and Access Control strategy is under review. · Safetell strategic review: Review advancing; costs cut, sales up → review ongoing; salary costs cut c.15%
-
07:00
Titon Holdings TON £9.3mAnnual Report ResultsFY25 was in line with expectations, and the turnaround is showing: gross margin rose from 28.0% to 32.9%, underlying EBITDA from £5k to £811k, and the underlying pre-tax loss narrowed to £40k.Turnaround plan with targets £15.8m · 170% of mcapin lineoutlook mixedfirst in 8 months −5.1% on the dayMoved: Develop a 3-5 year strategy by end of FY24: pending → delivered – The five-year strategic plan was launched in 2024 and is now being executed. · Meaningful gross margin improvement within 12-18 months: pending → delivered – Gross margin rose 4.9 points to 32.9%, with improvements in both business units. · Achieve 10% organic revenue growth and 15% net margin by 2028: pending → on_track – Management says FY25 positions the Group for further progress towards the 2028 targets. FY25 revenue growth was only 2.1%, against a 10% target.
-
07:00
Oxford Instruments OXIG £1,365mTrading Update Trading updateConfirms full-year adjusted operating profit in line with consensus (£70.2m-£73.0m) after a weak H1. Q3 I&A orders are growing, so the H2 recovery looks on course.Moved: NanoScience business sale: Agreed; awaiting regulatory approvals → Completed 2 January 2026 (closed) · Imaging & Analysis recovery: H1 actions taken; H2 recovery expected → Q3 orders +2.4%; Belfast savings delivering